Related Experiment Video
Updated: Mar 3, 2026

09:14
Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
4.7K
Splenic Epstein-Barr Virus-Associated Inflammatory Pseudotumor.
Chris Van Baeten, Jo Van Dorpe1
1From the Department of Pathology, Ghent University Hospital, Ghent, Belgium.
Archives of Pathology & Laboratory Medicine
|April 28, 2017
Summary
Splenic inflammatory pseudotumors (IPTs) are rare, challenging lesions. Epstein-Barr virus (EBV)-associated IPTs, particularly those without follicular dendritic cell markers, require careful diagnosis due to overlapping features with other splenic conditions.
Area of Science:
- Pathology
- Oncology
- Virology
Background:
- Splenic inflammatory pseudotumor (IPT) presents diagnostic challenges due to its varied etiology (infectious, autoimmune, reactive, neoplastic).
- Epstein-Barr virus (EBV)-associated IPTs are a specific subset characterized by EBV-infected spindle cells.
- IPT-like follicular dendritic cell tumor is the most common EBV-associated splenic IPT subtype.
Purpose of the Study:
- To review the epidemiology, clinical features, and pathogenesis of EBV-associated splenic IPTs.
- To highlight diagnostic challenges, especially for EBV-associated IPTs lacking follicular dendritic cell markers.
- To discuss the role of immunoglobulin G4 (IgG4)-positive plasma cells and granulomas in complicating diagnosis.
Main Methods:
- Review of existing literature on splenic inflammatory pseudotumors and EBV association.
- Analysis of histomorphology, immunohistochemistry, and electron microscopy findings.
- Discussion of pathogenesis and differential diagnosis of EBV-associated splenic lesions.
Main Results:
- EBV-associated splenic IPTs encompass lesions with and without follicular dendritic cell markers.
- Lesions lacking follicular dendritic cell markers are less characterized, increasing diagnostic difficulty.
- Increased IgG4-positive plasma cells and granulomas in some EBV-associated IPTs can mimic other conditions.
Conclusions:
- Accurate diagnosis of EBV-associated splenic IPTs requires careful integration of clinical, histologic, and immunohistochemical data.
- Understanding the spectrum of EBV-associated splenic IPTs, including rarer forms, is crucial for appropriate patient management.
- Further research is needed to fully elucidate the pathogenesis and refine diagnostic criteria for these challenging splenic lesions.

